Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells
Multidrug-resistant (MDR) tumors and cancer cell lines demonstrate a wide variety of biochemical changes. In this study we used drug-sensitive wild-type (wt) cancer cell lines and respective MDR subclones, and we demonstrate the accumulation of distinct lipids in MDR cells. These lipids were either...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 1996-08, Vol.271 (32), p.19530-19536 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Multidrug-resistant (MDR) tumors and cancer cell lines demonstrate a wide variety of biochemical changes. In this study we
used drug-sensitive wild-type (wt) cancer cell lines and respective MDR subclones, and we demonstrate the accumulation of
distinct lipids in MDR cells. These lipids were either absent or present at very low levels in drug-sensitive cells. The compounds,
termed lipid-1 and lipid-2, migrated on thin-layer chromatography as a doublet. They could be radiolabeled by incubating MCF-7-AdrR
(Adriamycin-resistant) breast cancer cells with [ 3 H]serine, [ 3 H]palmitic acid, or [ 3 H]galactose. Utilization of these precursors by MCF-7-wt cells for synthesis of lipid-1 and â2 was minimal. Two inhibitors
of sphingolipid biosynthesis, L -cycloserine and fumonisin B 1 , prevented the observed accumulation of the lipid compounds. An inhibitor of glucosylceramide synthesis, 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol,
completely abolished the formation of lipid-1 and â2 in MCF-7-AdrR cells and, to a lesser extent, inhibited the formation
of lactosylceramides and gangliosides. Utilizing mass spectrometry, the multidrug resistance-associated lipids were further
characterized as monoglycosylceramides of two major species that contained either 16-carbon (palmitic) or 24-carbon (lignoceric
and nervonic) fatty acids. The carbohydrate head group of glycosylceramides was identified as glucose, not galactose, thus
designating the accumulated lipids as glucosylceramides. Incorporation of [ 3 H]palmitic acid into glucosylceramide was strikingly higher (8-10 times) in MCF-7-AdrR cells compared with MCF-7-wt cells.
Since the rate of glucosylceramide degradation in MCF-7-AdrR cells was not attenuated, accelerated glycosphingolipid synthesis
in MDR cells is suggested. Glucosylceramide also accumulated in KB-V-1, a vinblastine-resistant epidermoid carcinoma but not
in KB-3-1, drug-sensitive wt cells. MDR ovarian adenocarcinoma cells (NIH:OVCAR-3) also contained elevated levels of glucosylceramide.
Our results demonstrate a correlation between cellular drug resistance and alterations in glucosylceramide metabolism. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.271.32.19530 |